Heart procedure may offer lasting migraine relief, new study hopes to prove
NCT ID NCT07629635
First seen Jun 27, 2026 · Last updated Jul 30, 2026 · Updated 2 times
Summary
This study looks at people with migraines who also have a small hole in the heart (PFO). Participants first take a blood-thinning drug (prasugrel) to see if their migraines improve. Those who respond are randomly assigned to either continue the drug alone or have a procedure to close the hole plus the drug. After stopping the drug, researchers check if the closure group has fewer migraines. The goal is to find a lasting treatment for migraine sufferers.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIGRAINE DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Columbia University Irving Medical Center - NewYork Presbyterian Hospital (CUIMC/NYP)
New York, New York, 10032, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can closing a hole in the heart prevent future strokes? a long-term study seeks answers.
- New heart device aims to seal Stroke-Causing hole
- Real-world study tests migraine drug atogepant over 12 months in tough-to-treat patients
- Scientists aim to forecast migraine pain using wearable sensors and early symptoms
- Can targeted supplements ease migraine suffering? new trial investigates
- New migraine sprays and tablets tested in ER for quick relief